Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 3,331 | 4,459 | 8,183 | 4,378 | 4,407 |
| Operating Income | -3,331 | -4,459 | -8,183 | -4,378 | -4,407 |
| Other Income | 68 | -16 | 41 | 383 | -302 |
| Pre-tax Income | -3,264 | -4,475 | -8,142 | -3,994 | -4,710 |
| Income Tax | 505 | 11 | 1 | 20 | 15 |
| Net Income Continuous | -3,768 | -4,486 | -8,143 | -4,014 | -4,724 |
| Net Income | $-3,768 | $-4,486 | $-8,143 | $-4,014 | $-4,724 |
| EPS Basic Total Ops | -0.08 | -0.17 | -0.42 | -0.22 | -0.29 |
| EPS Basic Continuous Ops | -0.08 | -0.17 | -0.42 | -0.22 | -0.29 |
| EPS Diluted Total Ops | -0.08 | -0.17 | -0.42 | -0.22 | -0.29 |
| EPS Diluted Continuous Ops | -0.08 | -0.17 | -0.42 | -0.22 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.11 | -0.17 | -0.42 | N/A | N/A |
| EBITDA(a) | $-3,310 | $-4,437 | $-8,162 | $-4,357 | $-4,384 |